selegiline has been researched along with Dementia in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 9 (56.25) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arya, P; Butler, R; Warner, J | 1 |
| Bakhle, YS; Youdim, MB | 1 |
| Butler, R; Warner, J; Wuntakal, B | 1 |
| Brodsky, MA; Koudelka, C; Swarztrauber, K | 1 |
| Preskorn, SH | 1 |
| McFarland, HR | 1 |
| Szirmai, I; Tárczy, M | 1 |
| Bruyette, DS; Cotman, CW; Cummings, BJ; DePaoli, A; Head, E; Milgram, NW; Ruehl, WW | 1 |
| Bruyette, DS; Cummings, BJ; Hart, B; Head, E; Neilson, J; Ruehl, WW | 1 |
| Pryse-Phillips, W | 1 |
| Antonello, RM; Bava, A; Cazzato, G; Moretti, R; Torre, P | 1 |
| Schneider, LS; Sobin, PB | 1 |
| Lees, AJ | 1 |
| Nagatsu, T; Naoi, M | 1 |
| Curry, SH; Eatough, VM; Frankel, JP; Kempster, PA; Lees, AJ; Rogers, D; Stern, GM | 1 |
| Martini, E; Pataky, I; Szilágyi, K; Venter, V | 1 |
7 review(s) available for selegiline and Dementia
| Article | Year |
|---|---|
Dementia.
Topics: Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Cognition; Dementia; Donepezil; Galantamine; Ginkgo biloba; Haloperidol; Humans; Indans; Memantine; Olanzapine; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Risperidone; Rivastigmine; Selegiline; Tacrine; Vitamin E | 2004 |
Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness.
Topics: Animals; Cholinesterase Inhibitors; Dementia; Depressive Disorder; History, 20th Century; History, 21st Century; Humans; Indans; Iron; Iron Deficiencies; Isoenzymes; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Parkinson Disease; Selegiline | 2006 |
Dementia.
Topics: Alzheimer Disease; Benzodiazepines; Dementia; Donepezil; Galantamine; Ginkgo biloba; Humans; Indans; Memantine; Nootropic Agents; Olanzapine; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Rivastigmine; Selegiline; Tacrine | 2005 |
Canine cognitive dysfunction as a model for human age-related cognitive decline, dementia and Alzheimer's disease: clinical presentation, cognitive testing, pathology and response to 1-deprenyl therapy.
Topics: Aging; Alzheimer Disease; Animals; Cognition Disorders; Dementia; Disease Models, Animal; Dogs; Humans; Selegiline | 1995 |
Do we have drugs for dementia? No.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Donepezil; Ginkgo biloba; Humans; Indans; Neuroprotective Agents; Nootropic Agents; Phytotherapy; Piperidines; Plants, Medicinal; Selegiline; Tacrine; Vitamin E | 1999 |
Non-neuroleptic treatment of behavioral symptoms and agitation in Alzheimer's disease and other dementia.
Topics: Adrenergic beta-Antagonists; Alzheimer Disease; Buspirone; Carbamazepine; Dementia; Humans; Lithium; Neurotransmitter Uptake Inhibitors; Selegiline; Serotonin; Trazodone | 1992 |
Selegiline hydrochloride and cognition.
Topics: Aged; Alzheimer Disease; Attention; Dementia; Depressive Disorder; Humans; Mental Recall; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Reaction Time; Selegiline | 1991 |
2 trial(s) available for selegiline and Dementia
| Article | Year |
|---|---|
Effects of selegiline on fronto-temporal dementia: a neuropsychological evaluation.
Topics: Dementia; Humans; Middle Aged; Monoamine Oxidase Inhibitors; Selegiline | 2002 |
Effects of L-deprenyl on parkinsonian bradyphrenia.
Topics: Adult; Attention; Cognition Disorders; Dementia; Double-Blind Method; Humans; Microcomputers; Middle Aged; Neuropsychological Tests; Parkinson Disease; Psychomotor Performance; Reaction Time; Selegiline | 1990 |
7 other study(ies) available for selegiline and Dementia
| Article | Year |
|---|---|
Initial pharmacotherapy in a population of veterans with Parkinson disease.
Topics: Age Factors; Aged; Aged, 80 and over; Amantadine; Antiparkinson Agents; Cholinergic Antagonists; Databases, Factual; Dementia; Dopamine Agonists; Drug Prescriptions; Drug Utilization; Geriatrics; Humans; Levodopa; Male; Medicine; Middle Aged; Neurology; Northwestern United States; Parkinson Disease; Practice Patterns, Physicians'; Primary Health Care; Psychiatry; Psychology; Retrospective Studies; Selegiline; Specialization; United States; United States Department of Veterans Affairs; Veterans | 2006 |
Multiple medication use presenting as Parkinson's dementia complex: a message from Titanic.
Topics: Aged; Anti-Infective Agents; Antiparkinson Agents; Antipsychotic Agents; Bacteriuria; Ciprofloxacin; Dementia; Drug Interactions; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Fluoxetine; Haloperidol; Hospitalization; Humans; Hypnotics and Sedatives; Lorazepam; Parkinson Disease; Psychomotor Agitation; Selegiline; Trihexyphenidyl | 2008 |
Treatment of Parkinson's disease.
Topics: Antiparkinson Agents; Costs and Cost Analysis; Dementia; Humans; Parkinson Disease; Physical Therapy Modalities; Selegiline | 1993 |
Failure of dopamine metabolism: borderlines of parkinsonism and dementia.
Topics: Antiparkinson Agents; Brain; Chronic Disease; Dementia; Dopamine; Humans; Neuropsychological Tests; Organotechnetium Compounds; Oximes; Parkinson Disease; Selegiline; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1995 |
Therapeutic actions of L-deprenyl in dogs: a model of human brain aging.
Topics: Aging; Animals; Brain; Cognition Disorders; Dementia; Dogs; Humans; Models, Biological; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Selegiline | 1998 |
[Monoamine oxidase inhibitors].
Topics: Antidepressive Agents; Dementia; Humans; Monoamine Oxidase Inhibitors; Parkinson Disease; Selegiline | 1991 |
Brief information on an early phase-II study with deprenyl in demented patients.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Drug Evaluation; Female; Humans; Phenethylamines; Selegiline | 1987 |